Comparison of efficacy with haloperidol versus ondansetron on postoperative nausea and vomiting in laparoscopic sleeve gastrectomy

Phase 3

Recruiting

• Conditions: laparoscopic sleeve gastrectomy.; Acquired absence of stomach [part of]; Z90.3

• Registration Number: IRCT20221108056438N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Informed consent
All patients who are candidates for LSG surgery
ASA Class I and II
between 18 and 60 years old

Exclusion Criteria

Patients with an underlying disease that is not currently under control.
Patients who have a history of allergy to haloperidol or ondansetron.
Patients who have a history of alcohol consumption, use of antidepressants and drug addiction (if they become symptomatic by not taking)
pregnant women
Lactating women
People suffering from anxiety disorders, restlessness, tremors, convulsions, tinnitus
Cases in which the surgeon decides to change the surgical procedure for any reason during the operation
Patients who have a history of bradycardia, hypotension, cardiovascular collapse and respiratory arrest.
Patients who have used an anti-nausea and vomiting agent within 24 hours before surgery.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ausea and vomiting. Timepoint: Every 15 minutes in recovery and every hour in the ward. Method of measurement: They will be evaluated based on VAS or Visual Analogue Scale.